M 943 Pill: blue, round, 9mm
The pill with imprint M 943 (Blue, Round, 9mm) has been identified as Divalproex Sodium Delayed-Release 125 mg and is used for Bipolar Disorder, Mania, Migraine Prevention, Seizures, and Epilepsy. It belongs to the drug class fatty acid derivative anticonvulsants and is not a controlled substance.
Images for M 943


Divalproex Sodium Delayed-Release
- Imprint
- M 943
- Strength
- 125 mg
- Color
- Blue
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Fatty acid derivative anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-1043 (Discontinued)
- Inactive Ingredients
-
ferrosoferric oxide,
silicon dioxide,
copovidone,
croscarmellose sodium,
FD&C Blue No. 2,
FD&C Yellow No. 6,
hypromelloses,
lactose monohydrate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
microcrystalline cellulose,
polydextrose,
polyethylene glycol,
polysorbate 80,
polyvinyl alcohol,
propylene glycol,
sodium hydroxide,
magnesium silicate,
titanium dioxide,
triacetin,
triethyl citrate
Note: Inactive ingredients may vary.
Related images for "M 943"
More about divalproex sodium
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (514)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: fatty acid derivative anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Depakote, Depakote ER, Depakote Sprinkles
Professional resources
- Divalproex Capsules prescribing information
- Divalproex Delayed Release (FDA)
- Divalproex Delayed Release Tablets (FDA)
- Divalproex Extended Release (FDA)
- Divalproex Sprinkle (FDA)
Other brands
Depakote, Depakote ER, Depakote Sprinkles
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.